Encapsulate

2 known investors

Encapsulate develops automated tumor-on-a-chip diagnostic systems that predict cancer patients' treatment responses by screening patient-derived microtumors against therapeutic regimens. The platform serves oncologists, pharmaceutical companies, and researchers seeking personalized cancer therapy insights and preclinical drug testing capabilities.

BiotechDigital HealthMedical Devices